Our History

Kadima Neuropsychiatry Institute was founded by David Feifel, MD, PhD, a master clinician, certified neuropsychiatrist and accomplished brain scientist. Dr. Feifel was a full Professor of Psychiatry at UC San Diego for over twenty years during which he established several successful clinical and research programs focusing on advanced treatments. In 2017, Dr. Feifel decided to resign his full-time, tenured appointment at UCSD and establish Kadima to more effectively pursue his vision of creating a center focused on developing and utilizing innovative, non-invasive treatments. Dr. Feifel maintains an active appointment as Professor Emeritus of Psychiatry, within UCSD’s School of Medicine.

Our Name

Kadima means “forward” in Hebrew and it embodies our philosophy; we continually strive to move the treatment of neuropsychiatric conditions forward, and along with it, the quality of our patients’ lives.

Our Mission

The mission of Kadima Neuropsychiatry is to help people with neuropsychiatric conditions move their lives forward. We do this by being forward-looking ourselves; utilizing the most advanced and innovative brain treatments, administered compassionately by eminently skilled providers

Our Logo

A human-like letter ”K” holds aloft a brain in one hand while pointing forward (kadima) with the other hand, evoking the notion of advancing the state of brain treatments in general as well as the brain function of our patients specifically. Likewise, two upwardly pointing arrow-like “A’ letters evoke the notion of raising the effectiveness of brain treatments and the quality of our patients’ lives.

Our Vision

Kadima Neuropsychiatry Institute will:

  • *be the leader in providing the effective treatments for neuropsychiatric conditions. It will do this by utilizing the most advanced, innovative treatment interventions in an integrative and compassionate fashion.
  • *take full advantage of the rapidly evolving, revolutionary advances now taking place in brain medicine, such as non-invasive neuromodulation (e.g. TMS) and therapeutic use of psychedelic drugs.
  • *continually seek out and adopt additional, evidenced-based treatments to help people whose lives are being impeded by a neuropsychiatric condition.
  • *contribute to the revolutionary advances in brain medicine by developing innovative treatments and finding ways to optimize the use of existing ones.
  • *be the brain treatment center that doctors and their patients’ will turn to when conventional treatments have fallen short.

Our Leadership

Dr. David Feifel earned a Bachelor of Science, Master’s Degree and a Ph.D. (Neurobiology) from the University of Toronto, Canada. He also earned a Medical Degree from University of Toronto’s Medical School, one of the top ranked in the world. After completing an internship in Internal Medicine at the Toronto General Hospital, Dr. Feifel completed a Psychiatry residency  at the University of California, San Diego, serving as outpatient Chief Resident in his final year. Upon finishing his residency, he was recruited to join UCSD’s School of Medicine as a faculty member and rose to rank of full Professor in the Department of Psychiatry and in the Neuroscience graduate program.

At UCSD Dr. Feifel was Director of the Neuropsychiatry and Behavioral Medicine Program, was the founder and Director of the UCSD Adult ADHD program, and created the Department of Psychiatry’s Center for Advanced Treatment where he introduced several novel treatments such as Transcranial Magnetic Stimulation (TMS) and Ketamine. He was one of the first providers in the country to utilize these treatments. At UCSD, Dr. Feifel also regularly taught medical students, residents and postdoctoral fellows and headed a translational research program focused on developing new treatments for psychiatric disorders.

In 2017, Dr. Feifel decided to resign his full-time tenured appointment at UCSD and established Kadima Neuropsychiatry Institute and the Kadima Brain Initiative in order to more effectively pursue his passion for developing and utilizing cutting edge, non-invasive treatments for neuropsychiatric disorders. Dr. Feifel maintains an active appointment as Professor Emeritus of Psychiatry, within UCSD’s School of Medicine

Among his distinctions, Dr. Feifel is an elected member of the American College of Neuropharmacology, he has been elected by his peers for inclusion in ‘Best Doctors in America’, and he is cited in the Castle Connelly list of  “Top Doctors:” a distinction bestowed on only 10 psychiatrists in San Diego.

In addition to being a Diplomate of the American Board of Psychiatry and Neurology in General Psychiatry, he is also certified in the sub-specialties Psychosomatic Medicine, and holds certification from the United Council of Neurological subspecialties in Behavioral Neurology and Neuropsychiatry, a certification only held by only three physicians in San Diego.

Dr. Feifel continues to conduct research into developing new treatment approaches to mental illness at Kadima Neuropsychiatry Institute and he heads an NIH funded research laboratory at the VA Medical Center in San Diego. He has authored or co-authored over 100 original scientific research papers and multiple research abstracts and book chapters on the topic of psychiatric illness and their treatments. Dr. Feifel lectures internationally on novel treatments for brain disorders. His research has received funding grants from the National Association for Research in Schizophrenia and Depression (NARSAD), the Scottish Rite Organization, the Stanley Medical Research Institute, Kavli Institute for Brain and Mind and the National Institutes of Health (NIH).